{"actual":false,"contact":[{"telecom":[{"system":"url","value":"http://www.hl7.org/Special/committees/dss"}]}],"contained":[{"characteristic":[{"code":{"text":"Defined by Reference"},"description":"IV alteplase 0.9 mg/kg (maximum 90 mg) as 10% of dose over 1 minute and 90% over 1 hour","exclude":false,"valueUri":"http://example.org/fhir/ActivityDefinition/example-alteplase-dosing"}],"id":"Definition-Group","membership":"conceptual","resourceType":"Group","title":"VariableDefinition: Alteplase for Stroke"}],"definition":{"reference":{"reference":"#Definition-Group"}},"description":"Alteplase for Stroke","extension":[{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-wg","valueCode":"cds"}],"id":"example-alteplase-for-stroke","name":"AlteplaseForStroke","publisher":"HL7 International / Clinical Decision Support","resourceType":"EvidenceVariable","status":"draft","text":{"div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      \n      <p>\n        \"Alteplase for Stroke\" is an exposure concept with a detailed dosing instruction that may be used in expressing what an Evidence is about.\n      </p>\n\t\n    </div>","status":"generated"},"title":"Alteplase for Stroke"}